Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in ...

Acts of discrimination, including subtle microaggressions, during pregnancy and childbirth contribute to higher maternal ...

Adding serial circulating tumor DNA (ctDNA) assays to standard of care imaging surveillance had limited clinical benefits in patients with resected colorectal cancer (CRC).

With high biologic treatment failure rates common among patients who have hidradenitis suppurativa (HS), investigators set ...

Trend tracking and harm reduction policies may help alleviate the high rate of overdose deaths in the US, according to one ...

Doctors conducted suicide risk assessments for 42% of patients flagged by interruptive alerts, compared with only 4% with ...

Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

Quality-of-life (QOL) outcomes vary widely for patients receiving first-line treatment for chronic lymphocytic leukemia (CLL) ...

The rates at which ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thin in the eyes was ...

Study highlights barriers to care, treatment preferences, and interest in research participation in psoriasis in the Latine ...

Record numbers have enrolled in Affordable Care Act (ACA) coverage as open enrollment continues through January 15, 2025.

For several years, investigators have been studying combinations that include ruxolitinib, sold as Jakafi, to treat ...